Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

TG THERAPEUTICS, INC.

TGTX · Nasdaq · CIK 0001001316 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

4 Form 4 transaction lines observed in the same window
1 sales · 3 option, withholding, award, gift or other lines

Last qualifying purchase2023-08-11 · WEISS MICHAEL S · $1.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Charney Laurence NDirector
○○▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-08-11 · WEISS MICHAEL S.

Recent Form 4 activity

0Purchases
2Sales
9Other Form 4 lines
7SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING1 sale line(s) · context only
OTHER3 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
30,634,421
Previous report
30,153,733
Avg daily volume
2,038,064
Days to cover
15.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2023-08-11WEISS MICHAEL SPurchase (P)COMMON STOCK100,000USD 10.13USD 1,013,000SEC filing ↗
2023-01-06Echelard YannPurchase (P)Common Stock9,000USD 10.64USD 95,760SEC filing ↗

Form 4 evidence

11 transaction lines in the latest 365-day window; 99 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-10Charney Laurence NSale (S)Common Stock5,000USD 54.96USD 274,800SEC filing ↗
2026-08-07Charney Laurence NGift (G)Common Stock950USD 0.00USD 0SEC filing ↗
2026-08-06Charney Laurence NGift (G)Common Stock5,100USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (9 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-10Charney Laurence NSale (S)Common Stock5,000USD 54.96USD 274,800SEC filing ↗
2026-08-07Charney Laurence NGift (G)Common Stock950USD 0.00USD 0SEC filing ↗
2026-08-06Charney Laurence NGift (G)Common Stock5,100USD 0.00USD 0SEC filing ↗
2026-01-29Charney Laurence NGift (G)Common Stock13,197USD 0.00USD 0SEC filing ↗
2026-01-28Charney Laurence NGift (G)Common Stock30,000USD 0.00USD 0SEC filing ↗
2026-01-08WEISS MICHAEL SAward / grant (A)Common Stock622,000USD 0.00USD 0SEC filing ↗
2026-01-08Power Sean AAward / grant (A)Common Stock90,000USD 0.00USD 0SEC filing ↗
2025-11-24Echelard YannSale (S)Common Stock5,000USD 32.57USD 162,850SEC filing ↗
2025-11-05WEISS MICHAEL SGift (G)Common Stock4,668,843USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerTGTX
CIK0001001316
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history99 transaction lines from 2020-06-17 to 2026-09-10
2 P purchase lines · 25 S sale lines · 72 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.